For the quarter ending 2026-03-29.
| Income Statement | 2026-03-29 | 2025-12-28 | 2025-09-28 | 2025-06-29 |
|---|---|---|---|---|
| Asset impairment charge | - | -4,850* | 9,700 | 0 |
| Goodwill impairment charge | - | 98,000* | 700,700 | 0 |
| Total revenues | 619,800 | 723,600 | 699,900 | 613,900 |
| Cost of sales, excluding amortization of intangibles | 356,000 | 403,200 | 364,300 | 339,000 |
| Selling, marketing and administrative | 199,300 | 194,400 | 186,900 | 178,000 |
| Research and development | 44,900 | 45,800 | 41,500 | 45,700 |
| Amortization of intangible assets | 46,800 | 45,600 | 47,700 | 47,900 |
| Restructuring, integration and other charges | 4,400 | -64,150* | 39,600 | 178,900 |
| Other operating expenses | 200 | 71,900 | 14,300 | 5,100 |
| Operating (loss) income | -31,800 | -66,300 | -704,800 | -180,700 |
| Interest expense, net | 51,100 | 51,000 | 46,100 | 40,500 |
| Gain on extinguishment of debt | - | 0 | -5,100 | - |
| Other (income) expense, net | 3,400 | 4,900 | -900 | -8,400 |
| Loss before income taxes | -79,500 | -112,400 | -756,900 | -229,600 |
| Provision for income taxes | 12,300 | 18,300 | -23,900 | 25,800 |
| Net loss | -91,800 | -130,700 | -733,000 | -255,400 |
| Basic EPS | -1.35 | -1.922 | -10.78 | -3.77 |
| Diluted EPS | -1.35 | -1.922 | -10.78 | -3.77 |
| Basic Average Shares | 68,200,000 | 68,000,000 | 68,000,000 | 67,700,000 |
| Diluted Average Shares | 68,200,000 | 68,000,000 | 68,000,000 | 67,700,000 |
QuidelOrtho Corp (QDEL)
QuidelOrtho Corp (QDEL)